This week there are only a few small IPO's that will bring the second quarter to a close. Overall analysts have commented that the second quarter for IPO's will go on record as much improved from the first quarter. Besides the Brexit market shakeup, the overall markets have been steady and the IPO markets have responded in kind.
To wrap up the quarter we will have a biotech that looks to continue the trend of biotech IPO's held up by insider buying. Also, we expect to see Tactile Systems and Gemphire Therapeutics take a second shot at a successful offering. Lastly we will see a medical REIT (real estate investment trust) try to become the second REIT IPO of 2016.
Syros Pharmaceuticals (SYRS ) is first up and plans to raise $60 million this week. According to their filings, the company is expanding on research of non-coding DNA to identify biomarkers that control the expression of disease-driving genes. Its lead candidate targets leukemia subsets and will enter a 40-patient Phase 2 trial in mid-2016. In keeping with the pattern of biotechs this year, insiders are committed to an interest of up to $35 million (58% of the deal) in shares on the offering. The company will release 4 million shares at a range of $14-16.
Global Medical REIT (GMRE ) hopes to raise $100 million by issuing 9.1 million shares at a range of $10-12. According to their filings, the company will use the proceeds to repay debt and complete the acquisition of two properties in Connecticut and Pennsylvania. The company currently owns 12 fully leased health care facilities in eight states, generating $6.7 million in annualized rent. Its facilities include acute-care hospitals, orthopedic surgery centers and other health care centers, with an average age of 10 years.
